Vascular insult accompanied by overexpressed heme oxygenase-1 as a pathophysiological mechanism in experimental neurolathyrism with hind-leg paraparesis

Biochemical and Biophysical Research Communications

Volumn 428, Issue 1, 2012, Pages 160-166

  Kawaguchi, Kimino ^a   Lambein, Fernand ^b   Kusama Eguchi, Kuniko ^a  

^a NIHON UNIVERSITY   (Japan)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Heme oxygenase 1; Hemorrhage; Motor neuron; Neurolathyrism; Spinal cord

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; HEME OXYGENASE 1; PROTOPORPHYRIN ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; LATHYRISM; MOTOR NEURON DISEASE; NICK END LABELING; NONHUMAN; PARAPLEGIA; PRIORITY JOURNAL; RAT; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; BETA-ALANINE; BLOOD VESSELS; DISEASE MODELS, ANIMAL; HEME OXYGENASE-1; HEMORRHAGE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LATHYRISM; LUMBOSACRAL REGION; MOTOR NEURONS; PARAPARESIS; RATS; RATS, WISTAR; SPINAL CORD;

LATHYRUS SATIVUS; PISUM SATIVUM; RATTUS;

EID: 84868380631     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.032     Document Type: Article

References (22)

1. Ludolph A.C., Spencer P.S. Toxic models of upper motor neuron disease. J. Neurol. Sci. 1996, 139:53-59.
2. Tshala-Katumbay D.D., Spencer P.S. Toxic disorders of the upper motor neuron system. Motor Neuron Disorders and Related Diseases 2007, 353-372. Elsevier, B.V. A.A. Eisen, P.J. Shaw (Eds.).
3. Getahun H., Mekonnen A., TekleHaimanot R., Lambein F. Epidemic of neurolathyrism in Ethiopia. Lancet 1999, 354:306-307.
4. F. Lambein, Y.H. Kuo, K. Kusama-Eguchi and F. Ikegami, 3-N-oxalyl-L-2,3-diaminopropanoic acid, a multifunctional plant metabolite of toxic reputation, ARKIVOC (ix), 2007, 45-52.
5. P.S. Spencer, Lathyrism, In: B.G. Vinken (Ed.), Handbook of Clinical Neurology, Intoxication of the Nervous System, Part II, vol. 65. Elsevier, North Holland, 1995, pp. 1-20.
6. Kawaguchi K., Yamada S., Kusama-Eguchi K. CCDN News 2012, 19:2-3.
7. Kusama-Eguchi K., Yamazaki Y., Ueda T., Suda A., Hirayama Y., Ikegami F., Watanabe K., May M., Lambein F., Kusama T. Hind-limb paraparesis in a rat model for neurolathyrism associated with apoptosis and an impaired vascular endothelial growth factor system in the spinal cord. J. Comp. Neurol. 2010, 518:928-942.
8. Garbuzova-Davis S., Saporta S., Haller E., Kolomey I., Bennett S.P., Potter H., Sanberg P.R. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One 2007, 2:e1205.
9. Nicaise C., Mitrecic D., Demetter P., De Decker R., Authelet M., Boom A., Pochet R. Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res 2009, 1301:152-162.
10. Zhong Z., Deane R., Ali Z., Parisi M., Shapovalov Y., O'Banion M.K., Stojanovic K., Sagare A., Boillee S., Cleveland D.W., Zlokovic B.V. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 2008, 11:420-422.
11. Man S., Ubogu E.E., Ransohoff R.M. Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain. Pathol. 2007, 17:243-250.
12. Alam J., Cook J.L. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr. Pharm. Des. 2003, 19:2449-2511.
13. Suttner D.M., Dennery P.A. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J. 1999, 13:1800-1809.
14. Kusama-Eguchi K., Ikegami F., Kusama T., Suda A., Ogawa Y., Igarashi K., Watanabe K. A rat model of neurolathyrism: repeated injection of l-beta-ODAP induces the paraparesis of the hind legs. Amino Acids 2005, 28:139-143.
15. Shibahara S., Müller R., Taguchi H., Yoshida T. Cloning and expression of cDNA for rat heme oxygenase. Proc. Natl. Acad. Sci. USA 1985, 82:7865-7869.
16. Carmeliet P., Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 2005, 436:193-200.
17. Garbuzova-Davis S., Hernandez-Ontiveros D.G., Rodrigues M.C., Haller E., Frisina-Deyo A., Mirtyl S., Sallot S., Saporta S., Borlongan C.V., Sanberg P.R. Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 2012, 1469:114-128.
18. Terry C.M., Clikeman J.A., Hoidal J.R., Callahan K.S. TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C Ca2+ and phospholipase A2 in endothelial cells. Am. J. Physiol. 1999, 276:H1493-H1501.
19. Vargas M.R., Pehar M., Cassina P., Martínez-Palma L., Thompson J.A., Beckman J.S., Barbeito L. Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes. J. Biol. Chem. 2005, 280:25571-25579.
20. Wang J., Doré S. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 2007, 130:1643-1652.
21. Ohnishi M., Katsuki H., Unemura K., Izumi Y., Kume T., Takada-Takatori Y., Akaike A. Heme oxygenase-1 contributes to pathology associated with thrombin-induced striatal and cortical injury in organotypic slice culture. Brain Res. 2010, 1347:170-178.
22. Uttara B., Singh A.V., Zamboni P., Mahajan R.T. Oxidative stress and neurodegenerative diseases a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7:65-74.